Clinical Trials Logo

Filter by:
NCT ID: NCT04845256 Completed - Breast Cancer Clinical Trials

Evaluation of SOMAVAC 100 Sustained Vacuum System

Start date: May 1, 2021
Phase:
Study type: Observational

The purpose of this research study is to compare the effectiveness of the Somavac 100 Sustained Vacuum System versus manual section bulbs after immediate breast reconstruction.

NCT ID: NCT04844983 Completed - Clinical trials for Squamous Cell Carcinoma in Situ

A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

Start date: May 18, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to evaluate safety, tolerability and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma (in situ) skin cancer (isSCC).

NCT ID: NCT04844840 Completed - Keloid Clinical Trials

A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

Start date: April 29, 2021
Phase: Phase 2
Study type: Interventional

Phase 2, randomized, double-blind, multiple arm, controlled study to evaluate safety & efficacy of various doses of STP705 in reducing post Keloidectomy keloid recurrence.

NCT ID: NCT04844762 Completed - Clinical trials for Smoking (Tobacco) Addiction

Addiction and Behavior Related to Menthol Cigarette Substitutes

MENTHOL
Start date: December 16, 2019
Phase: N/A
Study type: Interventional

The goal of the proposed study is to examine the abuse liability and substitutability of plausible menthol cigarette alternatives currently on the market, including menthol filtered little cigars (mFLC), menthol roll-your-own (mRYO) pipe tobacco and cigarette tubes, and non-menthol cigarettes (nmC). In addition, the study will elucidate real-time mechanisms including product characteristics and perceived effects associated with greater substitution.

NCT ID: NCT04844736 Completed - Lung Cancer Clinical Trials

Testing the Feasibility of a Simplified Workflow for Lung Cancer

Start date: May 28, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to see if adding an "extra" check by formal radiology review is possible without disrupting the normal processes that take place to develop and prepare a safe radiation treatment plan for patients.

NCT ID: NCT04844463 Completed - Healthy Clinical Trials

A Study of JNJ-68179280 in Healthy Participants

Start date: May 26, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of JNJ-68179280 compared with placebo after administration of single ascending oral doses of JNJ-68179280 administered to healthy participants (Part 1), multiple ascending oral doses of JNJ-68179280, administered to healthy participants once daily (Cohorts 1 through 4) or twice daily (Cohort 5) over 14 consecutive days (Part 2) and multiple ascending oral doses of an alternative JNJ-68179280 formulation, administered to healthy participants once daily over 14 consecutive days (Part 3 if conducted).

NCT ID: NCT04844450 Completed - Fatty Liver Disease Clinical Trials

A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795

Start date: April 29, 2021
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the safety and tolerability of single and multiple subcutaneous (SC) doses of JNJ-75220795.

NCT ID: NCT04844424 Completed - Healthy Clinical Trials

A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants

Start date: April 14, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the relative bioavailability and food effect of a single dose of milvexian administered as direct compression (DC) oral tablets and roller compacted (RC) oral tablets compared with milvexian administered as Phase 2 oral capsules (Part 1) and of new concept tablets consisting of a single dose of milvexian administered as oral Tablet 1 and Tablet 2 compared with milvexian administered as Phase 2 oral capsules (Part 3) in healthy participants under fasting and fed conditions; to characterize the pharmacokinetics (PK) of multiple twice daily (BID) doses for 5 days of milvexian administered as DC oral tablets and Phase 2 oral capsules in healthy participants (Part 2) and to assess the effects of dosing time and food timing on the PK of single-dose of milvexian Phase 3 oral tablet formulation in healthy participants (Part 4) and to evaluate the relative bioavailability of a single dose of milvexian administered as oral film-coated DC whole tablets, oral film-coated DC tablets dispersed in water and then mixed with apple sauce, and oral film-coated DC tablets dispersed in water and administered as a suspension using a nasogastric (NG) tube in healthy participants under fasting conditions (Part 5).

NCT ID: NCT04844281 Completed - Contact Lens Clinical Trials

Wear Experience With Daily Toric Contact Lenses Over a Long Day

Start date: May 11, 2021
Phase: N/A
Study type: Interventional

This study is evaluating the wear experience of a daily toric contact lens after 10, 12, 14, and 16 hours of lens wear.

NCT ID: NCT04844021 Completed - Suicide Clinical Trials

Adolescent and Child Suicide Prevention in Routine Clinical Encounters

ASPIRE
Start date: March 14, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to compare two approaches to implement an evidence-based firearm safety promotion program, S.A.F.E. Firearm, in pediatric primary care as a universal suicide prevention strategy. The first implementation approach is a prompt in the electronic health record (EHR; Nudge) reminding clinicians to a) discuss firearm storage and b) offer a free cable firearm lock during the pediatric well visit. The second implementation approach (Nudge+) includes both the EHR Nudge described above plus one year of support to the clinics in deploying the program (i.e., practice facilitation). The study also aims to identify how these strategies work and whether the S.A.F.E. Firearm program results in reduced unauthorized access to firearms by young people. The investigators hypothesize that a greater proportion of well-visits will have S.A.F.E. Firearm delivery documented in the electronic health record in Nudge+ clinics vs. Nudge clinics.